Michael T. McCaul's Neurocrine Biosciences ($NBIX) trades
Yes. Michael McCaul has disclosed 6 trades in $NBIX since 2023: 2 buys and 4 sales.
The most recently disclosed: a sale of $15K–$50K (up to $50K), made Nov 19, 2024 and disclosed Dec 16, 2024. From the close on Dec 16, 2024, the day it was disclosed, to the close on Oct 29, 2026, $NBIX rose 10.0%. By disclosed buys of $NBIX, Michael McCaul ranks No. 1 of the 2 people whose filings on Disclosed show trades in it: up to $150K.
- trades
- 6
- buys
- 2
- sales
- 4
- in buys
- up to$150K
Scan with your phone's cameraOpens the App Store or Google Play.Still held?
No, by the filings: the last sale on file, on Nov 19, 2024, was a full sale, and no purchase has been disclosed since.
Disclosed counts a position from the trades on file: each trade once, shares only, nothing after a full sale.
Every disclosed trade in $NBIX
6 trades · newest filing first- Sold$15K–$50K(up to $50K)+10.0%since filed
- Sold$15K–$50K(up to $50K)+10.0%since filed
- Sold$1K–$15K(up to $15K)+19.7%since filed
- Sold$50K–$100K(up to $100K)+32.8%since filed
- Bought$50K–$100K(up to $100K)+28.7%since filed
- Bought$15K–$50K(up to $50K)+28.7%since filed
Each move runs from the close on the day the trade was disclosed to the close on Oct 29, 2026.
Michael's other most-traded stocks
Be there when Michael files next
Copy the portfolio and your basket follows each new filing.
Amounts are the ranges the filings disclose, and "up to" is the top of a range; the actual amount and price are not disclosed. Each row links to the filing it came from. This is a public record turned into a page, not a recommendation and not a statement about why anyone traded. Disclosed is not affiliated with Michael T. McCaul.